Inhibition of high-mobility group box 1 as therapeutic option in autoimmune disease: lessons from animal models : Current Opinion in Rheumatology

Secondary Logo

Journal Logo

IMMUNOPATHOGENESIS AND TREATMENT OF AUTOIMMUNE DISEASES: Edited by Cee s GM Kallenberg

Inhibition of high-mobility group box 1 as therapeutic option in autoimmune disease

lessons from animal models

Schaper, Fleura; Heeringa, Peterb; Bijl, Marcc; Westra, Johannaa

Author Information
Current Opinion in Rheumatology 25(2):p 254-259, March 2013. | DOI: 10.1097/BOR.0b013e32835cee2d

Abstract

© 2013 Lippincott Williams & Wilkins, Inc.

You can read the full text of this article if you:

Access through Ovid